EUVIMEDObjevte EUVIMED
Systematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children

Zoë Vander Elst iD, Pieter-Jan Spiessens, Dorian Vanneste iD, Nada Dia iD, Matthias Gijsen iD, Isabel Spriet iD, Karel Allegaert iD, Erwin Dreesen iD, Anne Smits iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70530 ↗

At a glance

Systematische Übersicht in British Journal of Clinical Pharmacology, 2026. Written by Zoë Vander Elst and 8 co-authors. Institution: Department of Development and Regeneration, KU Leuven, Leuven, Belgium. Major MEDLINE topics: Vancomycin, Anti-Bacterial Agents, Models, Biological. Cited 2 times so far (Crossref); 129 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Research Foundation - Flanders (FWO).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Vancomycin is frequently used to treat gram‐positive infections in neonates and children. The optimal marker for efficacy and toxicity is the 24‐h area under the concentration‐time curve/minimal inhibitory concentration, which can be estimated using population pharmacokinetic (popPK) models. These models can be integrated into model‐informed precision dosing (MIPD) tools to personalize therapy. This study aimed to systematically review neonatal and paediatric vancomycin popPK models and develop a model selection tool for MIPD. A systematic literature search (December 2025; PubMed, EMBASE, WoS, Scopus, IPA) was conducted following PRISMA guidelines using the concepts ‘neonates/children’, ‘vancomycin’ and ‘popPK model’. Inclusion criteria were age 0–18 years, intravenous vancomycin, and popPK model development. Descriptive statistics summarized tested vs . retained covariates. Based on literature and multidisciplinary expert input, model selection criteria were proposed and applied to the identified models. Across 7915 articles, 112 popPK models were identified (1994–2025; 35 neonatal, 6 infantile, 39 paediatric, 2 adolescent, 30 mixed‐age). Models were built on data from median (range) 114 (6–7167) patients, representing 337 (26–13 372) PK samples. There were 81 one‐ and 30 two‐compartment models. Of 180 covariates tested across models, 47 (26.1%) were retained. Body weight was most frequently tested and retained (101/106, 95.3%). Model selection criteria included matching population, external and internal model evaluation (calibration, discrimination, uncertainty), cohort size, PK sampling schedule. The Chen (2023) model scored highest for both the neonatal and paediatric populations. This review and model selection tool can guide and standardize model selection for MIPD.

Subjects

MeSH terms (MEDLINE)

VancomycinAnti-Bacterial AgentsModels, BiologicalHumansInfant, NewbornChildChild, PreschoolInfantAdolescentPrecision MedicineArea Under Curve

Author keywords

neonatologypaediatricspharmacotherapypopulation analysistherapeutic drug monitoring

Substances

VancomycinAnti-Bacterial Agents

Authors and institutions

  • Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
  • Faculty of Medicine, KU Leuven, Leuven, Belgium.
  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
  • Department of Development and Regeneration, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

ORCID profiles: Zoë Vander Elst, Dorian Vanneste, Nada Dia, Matthias Gijsen, Isabel Spriet, Karel Allegaert, Erwin Dreesen, Anne Smits

Funding

  • Research Foundation - Flanders (FWO)

Cite

APA

Vander Elst, Z., Spiessens, P. J., Vanneste, D., Dia, N., Gijsen, M., Spriet, I., Allegaert, K., Dreesen, E., & Smits, A. (2026). Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70530

Vancouver

Vander Elst Z, Spiessens PJ, Vanneste D, Dia N, Gijsen M, Spriet I, et al. Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70530

BibTeX
@article{VanderElst2026,
  author = {Vander Elst, Zoë and Spiessens, Pieter-Jan and Vanneste, Dorian and Dia, Nada and Gijsen, Matthias and Spriet, Isabel and Allegaert, Karel and Dreesen, Erwin and Smits, Anne},
  title = {Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70530}
}
Start for free →